Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells.

MLA

Zarredar, Habib, et al. “Synergistic Effect of Novel EGFR Inhibitor AZD8931 and P38α SiRNA in Lung Adenocarcinoma Cancer Cells.” Anti-Cancer Agents in Medicinal Chemistry, vol. 19, no. 5, 2019, pp. 638–44. EBSCOhost, https://doi.org/10.2174/1871520619666190301125203.

APA

Zarredar, H., Farajnia, S., Ansarin, K., Baradaran, B., Aria, M., & Asadi, M. (2019). Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry, 19(5), 638–644. https://doi.org/10.2174/1871520619666190301125203

Chicago

Zarredar, Habib, Safar Farajnia, Khalil Ansarin, Behzad Baradaran, Maryam Aria, and Milad Asadi. 2019. “Synergistic Effect of Novel EGFR Inhibitor AZD8931 and P38α SiRNA in Lung Adenocarcinoma Cancer Cells.” Anti-Cancer Agents in Medicinal Chemistry 19 (5): 638–44. doi:10.2174/1871520619666190301125203.